LXRX FY 2023 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$704M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+766.2% YoY

Gross Profit

-$58M-4798.0% margin

Operating Income

-$172M-14265.0% margin

Net Income

-$177M-14710.9% margin

EPS (Diluted)

$-0.80

Cash Flow

Operating Cash Flow

-$162M

Free Cash Flow

-$162M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$229M

Total Liabilities

$136M

Stockholders' Equity

$93M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$139,000	+766.2%
Gross Profit	-$58M	-$52M	-10.3%
Operating Income	-$172M	-$101M	-70.5%
Net Income	-$177M	-$102M	-73.7%